Complexities of Glioblastoma Multiforme Clinical Trials

In honor of Glioblastoma (GBM) Awareness Day, Alaeddin Homsi, MS, BS, discusses this challenging indication

July 9, 2021 | Alaeddin Homsi, M.S., B.S.

As Glioblastoma (GBM) Awareness Day approaches, we recognize that glioblastoma multiforme (GBM) is a challenging indication that has not received any new approved therapies in well over a decade. New innovations are creating opportunities for therapeutic research, and Worldwide Clinical Trials is poised to support development in GBM treatments. In this short video, Alaeddin Homsi, MS, BS, Executive Director for Oncology Project Management, discusses Worldwide’s increasing commitment to oncology research and its recent work supporting GBM studies, in particular.

Your form has been successfully submitted!
VIEW VIDEO
Alaeddin Homsi, M.S., B.S.
MEET THE AUTHOR

Alaeddin Homsi, M.S., B.S.

Executive Director, Project Management, Oncology & Hematology
LEARN MORE